NHI mulls coverage as use of new Alzheimer's drugs starts in Taiwan

Two newly approved Alzheimer's drugs have been administered for the first time in Taiwan, offering new hope to patients in the early stages of the disease, although neither is currently covered by the National Health Insurance (NHI) system.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)